ctrl K

Aspire BioPharma Inc. (ASBP)

NASDAQ: ASBP · Real-Time Price · USD

0.34

-0.02 (-5.29%)

At close: May 02, 2025, 3:59 PM

0.38

11.59%

After-hours: May 02, 2025, 05:56 PM EDT

Aspire BioPharma Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-503.41K	-579.72K	-402.63K	-395.98K	-232.11K	-155.81K	-90.27K
Interest Income	548.68K	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-12.47M	-579.72K	-402.63K	-395.98K	-232.11K	-155.81K	-90.27K
Net Income	-12.47M	-581.21K	-403.12K	-396.46K	-232.59K	-155.81K	-90.27K
Selling & General & Admin	3.02M	541.22K	356.36K	349.71K	196.34K	130.53K	79.77K
Research & Development	28K	38.5K	46.27K	46.27K	35.77K	25.27K	10.5K
Other Expenses	-28K	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	3.02M	579.72K	402.63K	395.98K	232.11K	155.81K	90.27K
Interest Expense	891.62K	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	-38.83K	94.16K	77.48K	83.48K	39.64K	11K	11K
Cost & Expenses	3.02M	579.72K	402.63K	395.98K	232.11K	155.81K	90.27K
Income Tax Expense	n/a	1.49K	481.00	481.00	481.00	n/a	n/a
Shares Outstanding (Basic)	7.77M	45.94M	45.94M	45.94M	45.94M	45.94M	45.94M
Shares Outstanding (Diluted)	7.77M	45.94M	45.94M	45.94M	45.94M	45.94M	45.94M
EPS (Basic)	-0.27	-0.01	-0.01	-0.01	-0.01	-0.00	-0.00
EPS (Diluted)	-0.27	-0.01	-0.01	-0.01	-0.01	-0.00	-0.00
EBITDA	-8.98M	-415.84K	-238.76K	-232.11K	-232.11K	-155.81K	-90.27K
EBIT	-11.58M	-579.72K	-402.63K	-395.98K	-232.11K	-155.81K	-90.27K
Depreciation & Amortization	2.6M	163.87K	163.87K	163.87K	n/a	n/a	n/a